Capecitabine-based chemotherapy in early-stage triple-negative breast cancer: a meta-analysis

Overview of attention for article published in Frontiers in oncology, October 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 7 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 19,235 followers.

Frontiers | Capecitabine-based chemotherapy in early-stage triple-negative breast cancer: a meta-analysis https://t.co/iJ7JVdOmyQ

27 Oct 2023

Reply Repost Favourite

RT @FrontOncology: New research: Capecitabine-based chemotherapy in early-stage triple-negative breast cancer: a meta-analysis: Introductio…

27 Oct 2023

Reply Repost Favourite

RT @FrontOncology: New research: Capecitabine-based chemotherapy in early-stage triple-negative breast cancer: a meta-analysis: Introductio…

27 Oct 2023

Reply Repost Favourite

New research: Capecitabine-based chemotherapy in early-stage triple-negative breast cancer: a meta-analysis: Introduction The efficacy and safety of adjuvant capecitabine in early-stage triple-negative breast cancer remains undefined. A… https://t.co/wV4u

26 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.